3rd Edition of SOHO MENA 2025

Beirut · September 25 – 27

Al Habtoor City Beirut Hotel

Watch

Drop your 40‑second recap video here
Recommended: MP4 / WebM • 16:9

About SOHO MENA

Following the consecutive success of the 1st and 2nd SOHO MENA meetings and on behalf of the Third SOHO MENA 2025 Organizing Committee — Dr. Ali Bazarbachi, Dr. Georges Chahine, and Dr. Ahmad Ibrahim — in collaboration with The Lebanese Society of Hematology & Blood Transfusion (LSHBT) and its president Dr. Ali Taher, it is our pleasure to announce the 3rd SOHO MENA which will take place on September 25th, 26th, and 27th, 2025 at Al Habtoor City Beirut Hotel.

Speakers & Guests

SOHO MENA 2025 Organizing Committee

Dr. Ali Bazarbachi
Organizing Committee
Dr. Georges Chahine
Organizing Committee
Dr. Ahmad Ibrahim
Organizing Committee
In collaboration with LSHBT
President: Dr. Ali Taher

SOHO MENA 2025 Organizing Committee

Conference Program

Download Full Program (PDF)
12:45–13:00 Welcome Notes
13:00–14:00 Pharma Symposium — J&J (CLL)
Chair: Elias Jabbour, MD
Session 1 — Multiple Myeloma
  • 14:00–14:30 Frontline therapy in fit patients — Rachid Baz, MD
  • 14:30–15:00 Frontline therapy in unfit patients — Thierry Facon, MD
  • 15:00–15:30 Management of R/R MM; Bispecifics; CAR-Ts — Jean El-Cheikh, MD
  • 15:30–15:45 Q&A
15:45–16:15 Coffee Break
Session 2 — Lymphoma 1
  • 16:15–16:45 CAR-T / BiTEs / ADCs updates — Anna Sureda, MD
  • 16:45–17:15 Updates on T-cell lymphoma — Gandhi Damaj, MD
  • 17:15–17:45 Treatment of Hodgkin lymphoma — Georges Chahine, MD
  • 17:45–18:15 HSCT for Hodgkin lymphoma — Ali Bazarbachi, MD
  • 18:15–18:30 Q&A
18:30–19:00 Pharma Symposium
Session 3 — ALL
  • 09:00–09:20 Optimizing Ph+ ALL therapy — Elias Jabbour, MD
  • 09:20–09:40 Frontline ALL therapy — Hagop Kantarjian, MD
  • 09:40–10:00 Management of ETP-ALL & Ph-like ALL — Nitin Jain, MD
  • 10:00–10:20 Later-line therapies in ALL — Elias Jabbour, MD
  • 10:20–10:30 Q&A
10:30–10:45 Coffee Break
Session 4 — AML
  • 10:45–11:15 Frontline therapy (younger/fit) — Courtney DiNardo, MD
  • 11:15–11:45 Frontline therapy (older/unfit) — Tapan Kadia, MD
  • 11:45–12:05 Later-line & targeted / combinations — Naval Daver, MD
  • 12:05–12:20 Menin inhibitors in acute leukemia — Ghayyas Issa, MD
  • 12:20–12:35 Allo HSCT in AML — Iman Abu Dalle, MD
12:35–13:05 Pharma Symposium — J&J (MM)
13:05–13:25 Q&A
13:25–14:30 Lunch Break
Session 5 — MDS
  • 14:30–14:50 Management of low-risk MDS — Rami Komrokji, MD
  • 14:50–15:10 Management of high-risk MDS — Amer Zeidan, MD
  • 15:10–15:30 Allogeneic SCT in MDS & aplastic anemia — TBA
  • 15:30–15:40 Q&A
15:40–16:00 Coffee Break
Session 6 — CLL
  • 16:00–16:30 Optimizing frontline CLL therapy — Nitin Jain, MD
  • 16:30–17:00 Later-line therapies in CLL — Ahmad Al Huraiji, MD
  • 17:00–17:20 Evolving prognostic models in CLL — Ahmad Ibrahim, MD
  • 17:20–17:30 Q&A
17:30–18:00/18:30 Pharma Symposium
Session 7 — Biology
  • 18:30–18:50 Integrated evaluation of molecular abnormalities in AML — Sanam Loghavi, MD
  • 18:50–19:10 MRD assessment in hematologic malignancies — Rami Mahfouz, MD
  • 19:10–19:25 Q&A
08:15–09:15 Meet the Expert sessions
Session 8 — Lymphoma 2
  • 09:15–09:35 Updates on follicular lymphoma — Gilles Salles, MD
  • 09:35–09:55 Updates on mantle cell lymphoma — Olivier Hermine, MD
  • 09:55–10:00 Q&A
10:00–10:15 Coffee Break
10:15–10:45 Pharma Symposium
Session 9 — CML / MPN
  • 10:45–11:15 Optimizing therapies in MF — Ibrahim Yakoub Agha, MD
  • 11:15–11:45 How I treat PV — Rami Komrokji, MD
  • 11:45–12:15 Frontline CML; TFR — Giuseppe Saglio, MD
  • 12:15–12:45 Pharma Symposium — J&J (MM)
  • 12:45–13:05 Q&A
13:05–13:20 Closing Ceremony

Registration

Registration

Select your category and join SOHO MENA 2025.

  • Physicians — All sessions, exhibition, coffee breaks & lunches
  • Trainees / Students — Workshops, poster sessions, discounted fee
  • Nurses & Allied Health — Scientific sessions & certificate

Registration Form

Registration — General Registration Google Form

Venue & Accommodation

Al Habtoor City Beirut Hotel — a premier venue in the heart of Beirut. Details about room blocks and preferential rates will be shared here.

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Support & Links